Yue D, Xu S, Wang Q, Li X, et al. Updated Overall Survival and Exploratory Analysis From Randomized, Phase II EVAN Study of Erlotinib Versus Vinorelbine Plus Cisplatin Adjuvant Therapy in Stage IIIA Epidermal Growth Factor Receptor+ Non-Small-Cell Lung Cancer. J Clin Oncol 2022 Aug 26:JCO2200428. doi: 10.1200/JCO.22.00428.
PMID: 36027483